Last updated on July 2015

Study to Assess the Antipsychotic Efficacy of a Study Drug for Patients with Schizophrenia


Brief description of study

Study to Assess the Antipsychotic Efficacy of a Study Drug for Patients with Schizophrenia

Detailed Study Description

The study will evaluate the antipsychotic efficacy of ITI-007 in a randomized, double-blind, parallel-group, placebo- and active-controlled, multi-center study in patients diagnosed with schizophrenia having an acute exacerbation of psychosis.

Clinical Study Identifier: TX140932

Find a site near you

Start Over
Sorry. There are no research sites conducting this study in the radius provided. ( View all Sites )
If you would like to be informed of other studies that may be of interest to you, you may sign up for CenterWatch.com's Patient Notification Service. ( Sign Up )